PCVX | VaxcyteNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$60.81
+$0.19 (+0.31%)

Vaxcyte (PCVX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since Nov 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $60.81 vs 50 $61.54 / 200 $57.17
Projection
No cross projected
Test
No active test
Last cross
Golden cross 26 Nov 2025 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $62.03 vs 50 $55.07 / 200 $58.51
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 10 Nov 2025 ยท projected 30 bars out ยท tested 5 bars

4-hour as of 3 Nov 13:30 ET

Price
between the two $61.36 vs 50 $63.67 / 200 $58.93
Projection
No cross projected
Test
No active test
Last cross
Golden cross 21 Jul 2026 bar 2 ยท projected 28 bars out ยท tested 4 bars

Cross history

20
crosses on record since 2021
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
21 Jul 2026Golden4-hour28 bars out4 bar cross test
22 May 2026Death4-hour28 bars outNot tested
26 Nov 2025Golden steepdaily30 bars outNot tested
week of 10 Nov 2025Death steepweekly30 bars out5 bar cross test
6 Oct 2025Golden4-hour26 bars outโ€”

About PCVX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$86.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.